Science Explorer Back to mapMap
Discussion
Researcher · Roche (Switzerland) · Switzerland

Jorge Martinalbo

Jorge Martinalbo publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Economics and Econometrics, on topics such as Advanced Breast Cancer Therapies, Cancer Immunotherapy and Biomarkers and Breast Cancer Treatment Studies.

OpenAlex
World rank
#2,035,272
of 7,710,434 ranked researchers
Rank in Switzerland
#32,262
of 80,918
Works
23
Citations
380
Citations per work
16.5
h-index
7
i10-index 6Top 71% in Pulmonary and Respiratory Medicine
Jorge Martinalbo

What does Jorge Martinalbo research?

Jorge Martinalbo's work is mostly in Medicine (45%), Biochemistry, Genetics and Molecular Biology (21%), Economics, Econometrics and Finance (16%).

Health Sciences: 10 works · 44.8% of their workMedicine: 10 works · 44.8% of their workOncology: 5 works · 20.9% of their workPulmonary and Respiratory Medicine: 5 works · 20.9% of their workPhysiology: 1 works · 3.0% of their workLife Sciences: 5 works · 20.9% of their workBiochemistry, Genetics and Molecular Biology: 5 works · 20.9% of their workCancer Research: 3 works · 13.4% of their workGenetics: 2 works · 7.5% of their workEverything else: 4 works · 17.9% of their workSocial Sciences: 4 works · 16.4% of their workEconomics, Econometrics and Finance: 4 works · 16.4% of their workEconomics and Econometrics: 4 works · 16.4% of their workTHEIR WORKJorge Martinalbo23works
Life Sciences21%Health Sciences45%Social Sciences16%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1044.8%
    1. Biochemistry, Genetics and Molecular Biology520.9%
  3. Everything else417.9%
    1. Economics, Econometrics and Finance416.4%
  1. 1Pulmonary and Respiratory Medicine21% of their works
  2. 2Oncology21% of their works
  3. 3Economics and Econometrics16% of their works
  4. 4Cancer Research13% of their works
  5. 5Genetics8% of their works
  6. 6Physiology3% of their works

Research topics

Which keywords describe Jorge Martinalbo's research?

The keywords of their largest research topics: Breast Cancer, Metastatic Breast Cancer, CDK4/6 Inhibitors, Palbociclib, Quality of Life, Targeted Therapy, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 20 words, with their numbers
  1. Breast Cancer112 topics
  2. Metastatic Breast Cancer112 topics
  3. CDK4/6 Inhibitors81 topic
  4. Palbociclib81 topic
  5. Quality of Life82 topics
  6. Targeted Therapy82 topics
  7. Immune Checkpoint Blockade61 topic
  8. PD-1 and PD-L161 topic
  9. Breast Tumours51 topic
  10. Cost-effectiveness Analysis51 topic
  11. Gene Expression51 topic
  12. Health Utility Measures51 topic
  13. ALK Inhibitors41 topic
  14. Cancer Genomics41 topic
  15. EGFR Mutations41 topic
  16. Mutational Signatures41 topic
  17. Chemotherapy-Induced Peripheral Neuropathy31 topic
  18. Estrogen31 topic
  19. Receptor31 topic
  20. Taxanes31 topic

Where does Jorge Martinalbo work?

Jorge Martinalbo's main affiliation in the publication record is Roche (Switzerland), Switzerland.

How many publications and citations does Jorge Martinalbo have?

OpenAlex counts 23 works and 380 citations for Jorge Martinalbo, an h-index of 7, ranking #2,035,272 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Jorge Martinalbo. Posts are plain text and can be reported.